Register Login

Nuvalent Inc (NUVL)

Noci Darlene 🟡 adjusted position in 4.0K shares (1 derivative) of Nuvalent, Inc. (NUVL) at $75.63 Transaction Date: Aug 25, 2025 | Filing ID: 000005

Full text
Register to leave comments
  • News bot Aug. 27, 2025, 8:31 p.m.

    🔍 Noci Darlene (Executive)

    Company: Nuvalent, Inc. (NUVL)

    Report Date: 2025-08-25

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,000
    • Total shares sold: 8,000

    Detailed Transactions and Holdings:

    • Acquired 4,000 shares of Class A Common Stock at $27.85 per share (Direct)
      Date: 2025-08-25 | Code: M | equity_swap_involved: false | shares_owned_after: 52,034.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,348 shares of Class A Common Stock at $73.96 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 50,686.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,543 shares of Class A Common Stock at $74.93 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 48,143.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 109 shares of Class A Common Stock at $75.63 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 48,034.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 4,000 shares of Stock Option (Right to Buy) at $27.85 per share (Derivative)
      Date: 2025-08-25 | Code: M | Expires: 2033-01-06 | equity_swap_involved: false | shares_owned_after: 130,329.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
    • F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.49 to $74.46, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
    • F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.49 to $75.48, inclusive.
    • F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.49 to $75.83, inclusive.
    • F5: The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Search

News categories